ARTICLE
Case report
A 28-year-old man who had shown butterfly erythema, pancytopenia, and
high titers of anti nuclear antibody and anti DNA antibody, filling the
American College of Rheumatology (ACR) criteria for SLE twelve years before,
was treated with a maintenance dose of prednisolone (22.5 mg/day). He
had also received pulse therapy of 1,000 mg of methylprednisolone several
times during the two years after the onset because of thrombocytopenia.
With the exception of thrombocytopenia, cutaneous and systemic manifestations
suggestive of SLE were controlled successfully. He had no episodes of
atopic dermatitis, asthma, or susceptibility to viral and bacterial infections.
There was no familial history of immunological deficiencies. When he was
20 years old he experienced athletes foot and the lesion gradually expanded
despite therapy with topical antifungal cream. Pyodermic nodules developed
on his left leg and thigh, and increased in number and size during the
last 5 years.
He was referred to our clinic because of numerous purulent nodules and
ulcers on his left lower extremities. On examination, blackish necrotic
crusts adhered to the lesions (Fig.
1A), and yellowish pus drained from the fistulae. Scaly erythematous
plaques covered approximately 70% of his body surface (Fig.
1B). Hyperkeratosis was prominent on both of his soles. No cutaneous
lesions suggestive of SLE were observed.
Laboratory tests results are shown in Table
I. Total protein, albumin, total bilirubin, glutamic oxaloacetic
transaminase (GOT), glutamic pyruvic transaminase (GPT), serum urea nitrogen,
creatinine, urinalysis, antinuclear antibody, anti HTLV-1 antibody, and
anti HIV antibody were negative or within the normal range.
Hematoxylin and eosin (HE)-stained sections of biopsy specimens from
the edge of the ulcer showed a granulomatous reaction consisting of plasma
cells, neutrophils, lymphocytes, and giant cells (Fig.
2A, B). Small tiered and branched hyphae were observed in Grocott-stained
sections (Fig. 2C). Fungal
elements in the tissue were negative for anti Candida albicans
and Fusarium oxysporum antibodies. Purulent exudates from the cutaneous
lesions contained hyphae with smooth and thin walls (Fig.
3A). The exudates were cultured in Sabouraud's dextrose at 27°
C. Two different kinds of colonies grew. One was white to cream and had
a soft texture (Fig. 3B),
characteristic of Candida albicans and the other was white and
had a downy or cottony surface. The under side of the colony produced
a deep red pigment (Fig. 3C)
characteristic of T. rubrum, and small tear-shaped microconidia
arranged along the sides of the hyphae were observed by microscopy.
The patient was diagnosed as having Majocchi's granuloma due to T.
rubrum and Candida albicans coinfection. He was given 400 mg/day
of miconazole intravenously for six months and topical therapy with 1%
of clotrimazole cream. Candida albicans disappeared from the lesions
soon after the treatment, whereas the purulent discharge continued because
of persistent trichophytic granuloma. Oral itraconazole (200 mg/day) was
then added to the initial treatments four months later. The minimum inhibitory
concentration (MIC) of itraconazole for T. rubrum isolated from
the patient measured by using flat agar plates containing various concentrations
of itraconazole was 60 ng/ml. The concentrations of itraconazole in the
patient's serum and pus were 198 ng/ml (non hydrated) in serum, 430 ng/ml
(hydrated) in serum, and 210 ng/ml (non hydrated) in pus. Both flucytosine
(4,000 mg/day) and griseofulvin (500 mg/day) were administered for two
months to prevent coinfection of Candida albicans and the dissemination
of Candida albicans to the internal organs in a 26-year-old. This
treatment, however, also failed to resolve the lesions. Since the ulcers
and nodules were connected to form fistulae, the fistulae were washed
with miconazole, amphotericin B, and saline solution. Amphotericin B was
discontinued because of a severe decrease in the patient's platelet count
ten days later.
Immunological examinations
Several additional laboratory tests were done to evaluate more precisely
the patient's immunological state. The results are described in Table
II. Surface markers on his peripheral lymphocytes were evaluated
with flow cytometry. To evaluate neutrophil functions, fluorescent monodisperse
carboxylated microspheres phagocytized by neutrophils were measured by
flow cytometry, and oxidative product formation by measuring oxidized
dichlorofluorescein. NK cell function was determined by a 51Cr-release
assay using the K-562 cell line. The activation of the complement cascade
in the patient's and normal control sera was evaluated as described previously
[4]. Sera chelated with either ethylene glycol-bis (beta-amino-ethyl ether)
N, N'-tetraacetic acid (EGTA) or ethylenediamine tetraacetic acid (EDTA),
were incubated at 37° C for 1 hr with extracts from the isolated
T. rubrum strain or with 1% zymosan (Sigma, Missouri, USA). The
supernatant obtained after centrifugation was analyzed by immunoelectrophoresis
against anti-human C3c (DAKO, Denmark). The results demonstrated the conversion
of C3, from beta1a to beta1c, in both sera. This conversion was absent
in the EDTA-chelated serum, and present in the EGTA-chelated serum, indicating
that complement was activated by the alternative pathway. Lymphocytes
(1 x 106 cells/ml) were stimulated with 0.125% phytohaemagglutinin
(PHA), 5 mug/ml concanavalin A (Con A), or 50 mug/ml trichophytin (Kaken
Pharmaceutical, Tokyo in Japan), and 3H thymidine uptake was
measured 96 hrs later. The results are expressed as the stimulation index
(SI) (stimulated lymphocyte (c.p.m.)/unstimulated lymphocyte (c.p.m.)).
A delayed-type cutaneous response to PPD (0.05 mug) or trichophytin (50
mug) was not clearly demonstrated because of wide spreading of the tinea
lesions, a tendency to bleed at the injection site and the administration
of 12.5 mg/day of prednisolone. We examined the patterns of cytokine production
by peripheral blood mononuclear cells (PBMCs) stimulated with trichophytin
using a reverse transcriptase-polymerase chain reaction (RT-PCR) method.
PBMCs were obtained from the patient and from a volunteer who had an episode
of tinea pedis and a positive skin test reaction to trichophytin as a
control. Messenger RNA was extracted from the mononuclear cells after
stimulation with trichophytin (65 mug/ml) for 24 hrs, then RT-PCR was
performed. The following primer sets were used: IL-2; upstream, 5'- ATGTACAGGATGCAACTCCTGTCTT
-3'; downstream, 5'-GTCAGTGTTGAGATGATGCTTTGAC -3' (Ratagene, La Jolla,
CA, USA); IL-5; upstream, 5'- ATGAGGATGCTTCTGCATTTG -3'; downstream, 5'-
TCAACTTTCTATTATCCACTC -3'[5]; IL-10; upstream, 5'- ATGCCCCA AGCTGAGAACCAAGACCCA
-3'; downstream, 5'- TCTCAAGGGGCTGG GTCAGCTATCCCA -3'[6], IFN-gamma; upstream,
5'- ATGAAATATACAAGTTA TATCTTGGCTTT -3'; downstream, 5'- GATGCTCTTCGACCTCGAAACA
GCAT-3' (continental laboratory products incorporation, Burlington, MA,
USA) and beta-actin; upstream, 5'- TGACGGGGTCACCCACACTGTGCCCA TCTA -3';
downstream, 5'- CTAGAAGCATT TGCGGTGGACGATGGAGGG -3' (Ratagene, La Jolla,
CA, USA). The results of two independent experiments demonstrated expression
of IL-2 and IFN-gamma mRNAs by the patient's lymphocytes stimulated with
trichophytin. Expression of IL-5 and IL-10 mRNAs was not observed.
A remission has not been achieved yet, although systemic antifungal
treatments with 200 mg/day of oral itraconazole have continued for two
years, the dose of prednisolone has tapered every 6 months (12.5 mg/day),
and the lymphopenia has improved except for the NK-cell lymphopenia (data
not shown) and dysfunction as in Table
III.
Discussion
Host defense against fungi depends mainly on the innate and adaptive
immune systems [7]. Adaptive immunity has been focused on by many investigators
and is thought to be the most important immune defensive mechanism against
fungal infection. Many interesting discoveries in innate immunity, however,
are reported recently. Innate immune recognition regulates adaptive responses
by up-regulating the expression of costimulatory molecules on antigen-presenting
cells through toll-like receptors [8]. Lemaitre et al. described
how high susceptibility to fungal infection was induced in Drosophila
with a loss-of-function mutation in the toll gene [9]. It is likely that
trichophytic granuloma occurred in our case from immunodeficiency caused
by SLE and the long term prednisolone treatment. Various approaches to
treating the fungal infection were unsuccessful.
To find out the reasons for the incurability, we first investigated
the sensitivity of the causative T. rubrum to itraconazole. We
confirmed that our strain was sensitive to itraconazole and that the concentration
of itraconazole in the lesion was higher than the MIC. Smith et al.
[1] described how organisms in the dermis can change their morphology
and adapt to the environment. Therefore, the T. rubrum in the lesion
may become more resistant to itraconazole than the in vitro strain.
Next, we evaluated T cell-mediated immunity and innate immunity mediated
by neutrophils, NK cells, and complements against the fungus infection.
Lymphopenia (655 lymphocytes/mul) has improved twelve years after (1,974
lymphocytes/mul) although the lesions remain with several antifungal treatments.
This implies that lymphopenia was a cause of the onset of fungal infection
but other anti-fungal mechanisms might be still unable to improve the
lesions. Delayed-type hypersensitivity (DTH) to dermatophyte antigens
is mediated mainly by Th1 type cells secreting IL-2 and IFN-gamma, and
is correlated with the clinical course [10]. On the other hand, immediate
skin test responses are associated with chronic fungal infections [11].
The patient's PBMCs were activated and secreted Th1 type cytokines upon
stimulation with trichophytin. In addition, immediate skin responses were
not observed and anti-trichophyton IgE was slightly increased (0.56 UA/ml).
IgG increased without M-peak. These results indicate that T cell-mediated
immunity to T. rubrum is present in our patient.
As a general rule, neutrophils are the most effective killers of fungi
through phagocytosis and the release of oxidative products and lysosomal
enzymes. To show full-cytotoxic abilities, firstly, neutrophils must be
attracted to the infected lesions by chemotactic factors and signal to
kill the fungus through CD18 on neutrophils [7]. The phagocytic function
of the patient's neutrophils was within the normal range with a slight
decrease in the generation of oxidative products. Several fungi, including
T. rubrum, directly activate complement via the alternative
pathway causing the release of complement-derived chemotactic factors
which results in the accumulation of neutrophils in the lesions. The fungi
are opsonized by complement, and phagocytized by the neutrophils [12-14].
Each complement, C3 and C4 was in a normal range in the patient. In our
experiment, the patient's serum C3 was activated by zymosan and the fungal
extract to a similar extent as that from a normal control. We estimated
that both the complement activation pathway and the neutrophil functions
were normal in this patient since he had no episodes of susceptibility
to infections, although the defects of neutrophil chemotaxis, the expression
of CD18 molecule, and C5 have not yet evaluated.
NK cells with CD16 and CD56 surface antigens
are aggressive against fungi. NK cells binding to targets produce cytotoxic
molecules and lymphokines which stimulate other effector cells [7]. The
number and the function of NK cells were very low although lymphopenia
has improved twelve years later. In the assay of NK cell function, however,
there is a possibility that this assay might not show clinically relevant
results because a cytotoxicity to K-562 cell line, not to fungus, is evaluated.
We need to compare our case with other identical cases to confirm that
NK cell deficiency is a reason for incurability of T. rubrum infection
whereas we have not yet seen other cases like this nor found any previous
report describing the implications of severe NK cell deficiency in deep
mycosis. To analyse the function of NK cells directly in fungal infection
NK cell knockout mice may be a valuable tool. Our immunological evaluations
imply that the deficiency of innate immunity mediated by NK cells might
be responsible for a part of the recalcitrant trichophytic granuloma in
our case.
CONCLUSION
Acknowledgements
We would like to thank Dr. M. Ito (Shinshu University School of Medicine)
for performing the immunohistological staining.
REFERENCES
1. Smith KJ, Neafie RC, Skelton HD, Barrett TL, Graham JH, Lupton
GP. Majocchi's granuloma. J Cutan Pathol 1991; 18: 28-35.
2. Majocchi D. Sopra una nuova tricofizia (granuloma tricofitico),
studi clinici microgici. Bull R Acd Med Roma 1883; 9: 22-223.
3. Morikawa T. Granuloma trichophyticum Majocchi, hervorgerufen
von Sabouraudites uber (Castellani), Trichophyton purpureum (Bang). Arch
Dermatol Syph 1937; 176: 265-81.
4. Tagami H, Natsume N, Aoshima T, Inoue F, Suehisa S, Yamada
M. Analysis of transepidermal leukocyte chemotaxis in experimental dermatophytosis
in guinea pigs. Arch Dermatol Res 1982; 273: 205-17.
5. Vowels BR, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe
JT, et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell
lymphoma. J Invest Dermatol 1994; 103: 669-73.
6. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock
HW. Differential cytokine expression in human blood monocyte subpopulations:
a polymerase chain reaction analysis. Blood 1996; 87: 373-7.
7. Murphy JW. Mechanisms of natural resistance to human pathogenic
fungi. Ann Rev Microbiol 1991; 45: 509-38.
8. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med
2000; 343: 338-44.
9. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA.
The dorsoventral regulatory gene cassette spatzle/toll/cactus controls
the potent antifungal response in Drosophila adults. Cell 1996;
86: 973-83.
10. Wagner DK, Sohnle PG. Cutaneous defenses against dermatophytes
and yeasts. Clin Microbiol Rev 1995; 8: 317-35.
11. Jones HE, Reinhardt JH, Rinaldi MG. A clinical, mycological,
and immunological survey for dermatophytosis. Arch Dermatol 1973;
108: 61-5.
12. Swan JW, Dahl MV, Coppo PA, Hammerschmidt DE. Complement
activation by trichophyton rubrum. J Invest Dermatol 1983; 80:
156-8.
13. Tagami H, Kudoh K, Takematsu H. Inflammation and immunity
in dermatophytosis. Dermatologica 1989; 1: 1-8.
14. Kozel TR. Activation of the complement system by pathogenic
fungi. Clin Microbiol Rev 1996; 9: 34-46.
|